[A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
Belousov
Iu B
IuB
Upnitskiĭ
A A
AA
Sokolov
A V
AV
Tishchenkova
N F
NF
Karasev
A V
AV
Egorova
N A
NA
D000368:Aged; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D004110:Diltiazem / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology*; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D005082:Physical Exertion; D013997:Time Factors
D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D003692:Delayed-Action Preparations; D004110:Diltiazem
Kliniko-farmakologicheskoe issledovanie antianginal'noĭ i antiishemicheskoĭ éffektivnosti novoĭ lekarstvennoĭ formy diltiazema s zamedlennym vysvobozhdeniem.